Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization

Towards improving the efficacy of radiotherapy, one approach is to target the molecules and processes mediating cellular radioresponse. Along these lines, translational control of gene expression has been established as a fundamental component of cellular radioresponse, which suggests that the molec...

Full description

Bibliographic Details
Main Authors: Stacey L. Lehman, Evan D. Wilson, Kevin Camphausen, Philip J. Tofilon
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/19/10664
_version_ 1797516286949851136
author Stacey L. Lehman
Evan D. Wilson
Kevin Camphausen
Philip J. Tofilon
author_facet Stacey L. Lehman
Evan D. Wilson
Kevin Camphausen
Philip J. Tofilon
author_sort Stacey L. Lehman
collection DOAJ
description Towards improving the efficacy of radiotherapy, one approach is to target the molecules and processes mediating cellular radioresponse. Along these lines, translational control of gene expression has been established as a fundamental component of cellular radioresponse, which suggests that the molecules participating in this process (i.e., the translational machinery) can serve as determinants of radiosensitivity. Moreover, the proteins comprising the translational machinery are often overexpressed in tumor cells suggesting the potential for tumor specific radiosensitization. Studies to date have shown that inhibiting proteins involved in translation initiation, the rate-limiting step in translation, specifically the three members of the eIF4F cap binding complex eIF4E, eIF4G, and eIF4A as well as the cap binding regulatory kinases mTOR and Mnk1/2, results in the radiosensitization of tumor cells. Because ribosomes are required for translation initiation, inhibiting ribosome biogenesis also appears to be a strategy for radiosensitization. In general, the radiosensitization induced by targeting the translation initiation machinery involves inhibition of DNA repair, which appears to be the consequence of a reduced expression of proteins critical to radioresponse. The availability of clinically relevant inhibitors of this component of the translational machinery suggests opportunities to extend this approach to radiosensitization to patient care.
first_indexed 2024-03-10T06:59:07Z
format Article
id doaj.art-a3b224df23f34d1ab0cb04e40d08cffa
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:59:07Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a3b224df23f34d1ab0cb04e40d08cffa2023-11-22T16:13:27ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122191066410.3390/ijms221910664Translation Initiation Machinery as a Tumor Selective Target for RadiosensitizationStacey L. Lehman0Evan D. Wilson1Kevin Camphausen2Philip J. Tofilon3Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USARadiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USARadiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USARadiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USATowards improving the efficacy of radiotherapy, one approach is to target the molecules and processes mediating cellular radioresponse. Along these lines, translational control of gene expression has been established as a fundamental component of cellular radioresponse, which suggests that the molecules participating in this process (i.e., the translational machinery) can serve as determinants of radiosensitivity. Moreover, the proteins comprising the translational machinery are often overexpressed in tumor cells suggesting the potential for tumor specific radiosensitization. Studies to date have shown that inhibiting proteins involved in translation initiation, the rate-limiting step in translation, specifically the three members of the eIF4F cap binding complex eIF4E, eIF4G, and eIF4A as well as the cap binding regulatory kinases mTOR and Mnk1/2, results in the radiosensitization of tumor cells. Because ribosomes are required for translation initiation, inhibiting ribosome biogenesis also appears to be a strategy for radiosensitization. In general, the radiosensitization induced by targeting the translation initiation machinery involves inhibition of DNA repair, which appears to be the consequence of a reduced expression of proteins critical to radioresponse. The availability of clinically relevant inhibitors of this component of the translational machinery suggests opportunities to extend this approach to radiosensitization to patient care.https://www.mdpi.com/1422-0067/22/19/10664radiosensitizationeIF4EeIF4GeIF4AmTORribosome biogenesis
spellingShingle Stacey L. Lehman
Evan D. Wilson
Kevin Camphausen
Philip J. Tofilon
Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
International Journal of Molecular Sciences
radiosensitization
eIF4E
eIF4G
eIF4A
mTOR
ribosome biogenesis
title Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
title_full Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
title_fullStr Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
title_full_unstemmed Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
title_short Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
title_sort translation initiation machinery as a tumor selective target for radiosensitization
topic radiosensitization
eIF4E
eIF4G
eIF4A
mTOR
ribosome biogenesis
url https://www.mdpi.com/1422-0067/22/19/10664
work_keys_str_mv AT staceyllehman translationinitiationmachineryasatumorselectivetargetforradiosensitization
AT evandwilson translationinitiationmachineryasatumorselectivetargetforradiosensitization
AT kevincamphausen translationinitiationmachineryasatumorselectivetargetforradiosensitization
AT philipjtofilon translationinitiationmachineryasatumorselectivetargetforradiosensitization